We found that primary prostate tumors with FOXP2 expression had a higher Gleason grade than cases without FOXP2 expression by analyzing the clinical data of 491 human TCGA primary prostate tumors (Figure 1—figure supplement 4A). Here, FOXP2 is linked to prostate neoplasm.